Partnerships & Mergers

More than 3 million cases of complicated UTIs are recorded annually in the United States, and treatment failure affects up to one-third of patients.

Through the collaboration, the two companies aim to help healthcare providers improve efficiency, streamline operations, and enhance the quality of care delivered to patients.

The agreement brings together Protillion’s computational biology platform with Merck’s established drug development expertise to support the discovery of next-generation therapies.

The African Pooled Procurement Mechanism, led by the Africa Centres for Disease Control and Prevention, is designed to help Member States aggregate demand for medicines, vaccines, diagnostics, and other essential medical supplies.

The agreement was formalised during a signing ceremony held at ADCAN Pharma’s advanced manufacturing facility in Abu Dhabi, bringing together senior leadership from both organisations and key healthcare stakeholders.

The hospital introduced the programme as part of broader efforts to reduce the burden of airborne diseases through stronger community engagement and evidence-based interventions.

Under the new agreement, EDE and Novo Nordisk will work together to enhance pharmaceutical supply chain security by increasing in-country value creation and expanding strategic partnerships that help maintain a steady supply of medicines.

Under the agreement, EGT will oversee the rollout of Koios DS™ Breast and Koios DS™ Thyroid across key GCC markets, including the United Arab Emirates, Saudi Arabia, and Qatar.

Under the agreement, Servier will take control of Edgewise Therapeutics’ muscular dystrophy portfolio, including its lead candidate sevasemten.

The newly cleared technology aims to standardize routine ultrasound examinations, reduce variability between operators, and minimize the need for repeat scans.